TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07817134: An Open Label Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis

Sponsor: HALEON · Phase: PHASE4 · Area: IMMUNOLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$4,222,800

Rescue Site Savings

+$2,787,600

Unlock Full NCT07817134 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07817134 Rescue Dossier →